(Q52166326)

26 April 2018

title

Analgesic doses of the enkephalin degrading enzyme inhibitor RB 120 do not have discriminative stimulus properties. (English)

1 reference

26 April 2018

0 references

Hutcheson DM

1

1 reference

26 April 2018

Subhan F

2

1 reference

26 April 2018

Pache DM

3

1 reference

26 April 2018

Maldonado R

4

1 reference

26 April 2018

Fournié-Zaluski M

5

1 reference

26 April 2018

Roques BP

6

1 reference

26 April 2018

Sewell RD

7

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 August 2000

1 reference

26 April 2018

European Journal of Pharmacology

published in

1 reference

26 April 2018

volume

401

1 reference

26 April 2018

issue

2

1 reference

26 April 2018

page(s)

197-204

1 reference

26 April 2018

Effects of opioids and non-opioids on c-Fos-like immunoreactivity induced in rat lumbar spinal cord neurons by noxious heat stimulation.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Drug abuse potential evaluation in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Narcotic cue and narcotic state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Discriminative stimulus properties of narcotic analgesic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Investigations on drug produced and subjectively experienced discriminative stimuli. 2. Loperamide, an antidiarrheal devoid of narcotic cue producing actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Discriminative stimulus properties of fentanyl and morphine: Tolerance and dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Narcotic cuing and analgesic activity of narcotic analgesics: Associative and dissociative characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Narcotic cueing properties of intraventricularly administered sufentanil, fentanyl, morphine and met-enkephalin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Effect of inhibiting enkephalin catabolism in the VTA on motor activity and extracellular dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

New pharmacological strategies for pain relief

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

"Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

An investigation into the discriminative stimulus and reinforcing properties of the CCKB-receptor antagonist, L-365,260 in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Effect of 5-HT3 receptor antagonists on the discriminative stimulus properties of morphine in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Assessment of the abuse potential of acetorphan, an enkephalinase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Lack of physical dependence in mice after repeated systemic administration of the mixed inhibitor prodrug of enkephalin-degrading enzymes, RB101

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Pain-suppressive effects on various nociceptive stimuli (thermal, chemical, electrical and inflammatory) of the first orally active enkephalin-metabolizing enzyme inhibitor RB 120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Drugs of abuse: behavioural principles, methods and terms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900441-6

10.1016/S0014-2999(00)00441-6

7 January 2021

Identifiers

DOI

1 reference

26 April 2018

PubMed ID

10924927

1 reference

26 April 2018